Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 6Terminated 2Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Myeloid 1

Conditions

Leukemia, Myeloid, Acute 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Multiple Myeloma 7Lymphoma 6Leukemia 6Myelodysplastic Syndromes 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Primary Myelofibrosis 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Neoplasms, Plasma Cell 3Myeloproliferative Disorders 3Lymphoma, Non-Hodgkin 3Kidney Neoplasms 3Hodgkin Disease 3Wilms Tumor 2Thrombocythemia, Essential 2Rhabdomyosarcoma 2Recurrence 2Polycythemia Vera 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Neoplasms 2Lymphoma, T-Cell 2Lymphoma, Large B-Cell, Diffuse 2Graft vs Host Disease 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Thrombocytopenia 1Testicular Neoplasms 1

Interventions

Cyclophosphamide 12Methotrexate 9Antilymphocyte Serum 9fludarabine phosphate 8Tacrolimus 8Cyclosporine 8Mycophenolic Acid 6Whole-Body Irradiation 5Radiotherapy 5Busulfan 5thymoglobulin 4Sirolimus 4Methylprednisolone 4Filgrastim 4Alemtuzumab 4fludarabine 3Transplantation 3Rituximab 3Peripheral Blood Stem Cell Transplantation 3Melphalan 3Cord Blood Stem Cell Transplantation 3Thiotepa 2Therapeutics 2Stem Cell Transplantation 2Muromonab-CD3 2Immunosuppression Therapy 2Calcineurin Inhibitors 2visilizumab 1milatuzumab 1itacitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Graft vs Host Disease × Stem Cell Transplantation × Clear all
NCT00506948 2020-09-24

Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)

M.D. Anderson Cancer Center

Phase 2 Terminated
13 enrolled 5 charts
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Hematologic Neoplasms

NCT00473551 2011-12-19

Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
4 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡